In last trading session, Alzamend Neuro Inc (NASDAQ:ALZN) saw 0.45 million shares changing hands with its beta currently measuring -0.03. Company’s recent per share price level of $2.12 trading at -$0.07 or -3.20% at ring of the bell on the day assigns it a market valuation of $1.78M. That closing price of ALZN’s stock is at a discount of -1916.51% from its 52-week high price of $42.75 and is indicating a premium of 13.21% from its 52-week low price of $1.84. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.74 million shares which gives us an average trading volume of 1.60 million if we extend that period to 3-months.
For Alzamend Neuro Inc (ALZN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -2.38 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Alzamend Neuro Inc (NASDAQ:ALZN) trade information
Upright in the red during last session for losing -3.20%, in the last five days ALZN remained trading in the red while hitting it’s week-highest on Friday, 08/30/24 when the stock touched $2.12 price level, adding 23.47% to its value on the day. Alzamend Neuro Inc’s shares saw a change of -76.18% in year-to-date performance and have moved -7.42% in past 5-day. Alzamend Neuro Inc (NASDAQ:ALZN) showed a performance of 1.44% in past 30-days. Number of shares sold short was 25874.0 shares which calculate 0.49 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -11.45% during past 5 years.
Alzamend Neuro Inc (NASDAQ:ALZN)’s Major holders
Insiders are in possession of 24.22% of company’s total shares while institution are holding 4.52 percent of that, with stock having share float percentage of 5.96%. Investors also watch the number of corporate investors in a company very closely, which is 4.52% institutions for Alzamend Neuro Inc that are currently holding shares of the company.
